Metacrine, Inc. Insider Trading Activity
Every SEC Form 4 insider transaction reported for Metacrine, Inc. (MTCR), sourced directly from SEC EDGAR and updated as new filings are accepted.
Quick Answer
Are MTCR insiders buying or selling?
Metacrine, Inc. insiders reported 23 open-market buys ($119.5M) and 13 sells ($5.6M) across 36 Form 4 filings — a net buying position of $113.9M.
Source: SEC EDGAR Form 4
Key Statistics (as of Jan 27, 2023)
Insider sentiment
Net buyingNet insider flow of $113.9M in net buying.
Recent MTCR insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jan 27, 2023 | Michael York | Chief Business Officer | Sale | 107.1K | $0.41 | $44.3K |
| Jan 27, 2023 | Preston Klassen | President & CEO | Sale | 380.6K | $0.41 | $157.3K |
| Dec 21, 2022 | Braden Michael Leonard | 10% Owner | Purchase | 271.6K | $0.40 | $107.6K |
| Nov 9, 2022 | Braden Michael Leonard | 10% Owner | Purchase | 164.3K | $0.41 | $68.1K |
| Oct 31, 2022 | Braden Michael Leonard | 10% Owner | Purchase | 812.5K | $0.39 | $317.3K |
| Oct 26, 2022 | Braden Michael Leonard | 10% Owner | Purchase | 1.3M | $0.35 | $443.1K |
| Apr 20, 2022 | Preston Klassen | President & CEO | Sale | 44.7K | $0.50 | $22.5K |
| Dec 27, 2021 | Paul Edward Walker | 10% Owner | Sale | 497.3K | $0.99 | $494.5K |
| Dec 27, 2021 | Peter W. Sonsini | 10% Owner | Sale | 497.3K | $0.99 | $494.5K |
| Dec 27, 2021 | Scott D Sandell | 10% Owner | Sale | 497.3K | $0.99 | $494.5K |
| Dec 27, 2021 | Mohamad Makhzoumi | 10% Owner | Sale | 497.3K | $0.99 | $494.5K |
| Dec 27, 2021 | Anthony A. Florence Jr. | 10% Owner | Sale | 497.3K | $0.99 | $494.5K |
| Dec 27, 2021 | Carmen Chang | 10% Owner | Sale | 497.3K | $0.99 | $494.5K |
| Dec 27, 2021 | Ali Behbahani | 10% Owner | Sale | 497.3K | $0.99 | $494.5K |
| Dec 27, 2021 | Forest Baskett | 10% Owner | Sale | 497.3K | $0.99 | $494.5K |
| Dec 27, 2021 | New Enterprise Associates 16, L.P. | 10% Owner | Sale | 497.3K | $0.99 | $494.5K |
| Oct 26, 2021 | Corey S Goodman | 10% Owner | Sale | 615.7K | $1.51 | $928.9K |
| May 20, 2021 | Preston Klassen | President & CEO | Purchase | 20.5K | $3.64 | $74.7K |
| May 20, 2021 | Hubert C Chen | Chief Medical Officer | Purchase | 3.3K | $3.60 | $11.8K |
| Sep 22, 2020 | Paul Edward Walker | 10% Owner | Purchase | 769.2K | $13.00 | $10.0M |
| Sep 22, 2020 | Peter W. Sonsini | 10% Owner | Purchase | 769.2K | $13.00 | $10.0M |
| Sep 22, 2020 | Scott D Sandell | 10% Owner | Purchase | 769.2K | $13.00 | $10.0M |
| Sep 22, 2020 | Joshua Makower | 10% Owner | Purchase | 769.2K | $13.00 | $10.0M |
| Sep 22, 2020 | Mohamad Makhzoumi | 10% Owner | Purchase | 769.2K | $13.00 | $10.0M |
| Sep 22, 2020 | Anthony A. Florence Jr. | 10% Owner | Purchase | 769.2K | $13.00 | $10.0M |
Showing the 25 most recent of 36 Form 4 filings for Metacrine, Inc..
Most active MTCR insiders
- Braden Michael Leonard4 filings
- Preston Klassen3 filings
- Ali Behbahani2 filings
- Anthony A. Florence Jr.2 filings
- Carmen Chang2 filings
Ask anything about MTCR insider activity
Use Trabud's AI agent to query Metacrine, Inc.'s Form 4 history in plain English — "Show me MTCR CEO purchases this year" or compare it against any other ticker.
Open the AI agentMTCR insider trading FAQ
Are Metacrine, Inc. insiders buying or selling?
Across 36 SEC Form 4 filings, Metacrine, Inc. (MTCR) insiders reported 23 open-market purchases totaling $119.5M and 13 sales totaling $5.6M. That is a net buying position of $113.9M.
How many insiders trade MTCR stock?
21 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Metacrine, Inc.. The most recent filing was accepted on Jan 27, 2023.
Where does Trabud get MTCR insider trading data?
All MTCR insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.